Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
From CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
From CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
December 05, 2023
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
From CNBC.com News
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
From CNBC.com News
5 things to know before the stock market opens Monday
November 13, 2023
From CNBC.com News
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
November 02, 2023
From CNBC.com News
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
From CNBC.com News
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.